Demographic and clinical characteristics of the study population (n=134 074)
| All study population | |
|---|---|
| Age* | 59.18±15.00 |
| BMI* | 28.08±6.40 |
| Gender (F) | 55.8% |
| Residence (rural) | 22.7% |
| Smoking (current)† | 14.2% |
| Smoking (previous)† | 40.7% |
| Hypertension | 33.3% |
| Diabetes mellitus | 15.1% |
| History of dyslipidaemia | 21.7% |
| Cardiovascular diseases | 35.4% |
| Drugs with unintended lipid effects | 22.3% |
| Lipid lowering agent use | |
| Non-medication users | 86.2% |
| Single statin users | 11.9% |
| Combined medication users | 1.3% |
| Single usage of other lipid modifying agents | 0.6% |
| Lipid profile | |
| Total cholesterol* | 4.94±1.09 |
| HDL* | 1.39±0.42 |
| LDL* | 2.91±0.93 |
| Triglyceride* | 1.42±0.92 |
| Total cholesterol/HDL ratio* | 3.79±1.60 |
Figures are a percentage except for:
*Mean±SD.
†The statistics provided are according to the available information. Besides smoking and BMI which have missing rates close to 70% and 50%, respectively, the missing rates in all other variables are below 5% of the total population (n=134 074).
BMI, body mass index; HDL, high-density lipoprotein; TG, triglycerides.